{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:02:06Z","timestamp":1770984126292,"version":"3.50.1"},"reference-count":18,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Cancer Care"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1111\/ecc.12423","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:19:31Z","timestamp":1448266771000},"page":"e12423","source":"Crossref","is-referenced-by-count":6,"title":["The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients"],"prefix":"10.1155","volume":"26","author":[{"given":"Mehmet S.","family":"Uyanik","sequence":"first","affiliation":[{"name":"Department of Hematology; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum E.","family":"Pamuk","sequence":"additional","affiliation":[{"name":"Department of Hematology; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammet","family":"Maden","sequence":"additional","affiliation":[{"name":"Department of Hematology; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Merev","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokcen","family":"Cevik","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Edirne State Hospital; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesile","family":"Uyanik","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; Edirne State Hospital; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif G.","family":"Umit","sequence":"additional","affiliation":[{"name":"Department of Hematology; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet M.","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Hematology; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Akker","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Trakya University Medical Faculty; Edirne Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"10.1111\/ecc.12423-BIB0001|ecc12423-cit-0001","first-page":"280","article-title":"Validity and reliability of Turkish version of Hospital Anxiety and Depression scale","volume":"8","author":"Aydemir","year":"1997","journal-title":"Turkish Journal of Psychiatry"},{"key":"10.1111\/ecc.12423-BIB0002|ecc12423-cit-0002","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/10428194.2011.560310","article-title":"Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia","volume":"52","author":"Aziz","year":"2011","journal-title":"Leukaemia and Lymphoma"},{"key":"10.1111\/ecc.12423-BIB0003|ecc12423-cit-0003","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2011-04-347575","article-title":"Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population","volume":"118","author":"Efficace","year":"2011","journal-title":"Blood"},{"key":"10.1111\/ecc.12423-BIB0004|ecc12423-cit-0004","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00277-012-1458-6","article-title":"Which health-related quality of life aspects are important to patients with chronic myeloid leukemia receiving targeted therapies and to health care professionals? GIMEMA and EORTC Quality of Life Group","volume":"91","author":"Efficace","year":"2012a","journal-title":"Annals of Hematology"},{"key":"10.1111\/ecc.12423-BIB0005|ecc12423-cit-0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2011.02.007","article-title":"Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: inclusion of quality of life and other patient-reported outcomes","volume":"81","author":"Efficace","year":"2012b","journal-title":"Critical Reviews in Oncology Hematology"},{"key":"10.1111\/ecc.12423-BIB0006|ecc12423-cit-0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.leukres.2012.10.021","article-title":"Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review","volume":"37","author":"Efficace","year":"2013","journal-title":"Leukemia Research"},{"key":"10.1111\/ecc.12423-BIB0007|ecc12423-cit-0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11136-013-0523-5","article-title":"International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24","volume":"23","author":"Efficace","year":"2014","journal-title":"Quality of Life Research"},{"key":"10.1111\/ecc.12423-BIB0008|ecc12423-cit-0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2354.2003.00435.x","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30","volume":"13","author":"Guzelant","year":"2004","journal-title":"European Journal of Cancer Care (England)"},{"key":"10.1111\/ecc.12423-BIB0009|ecc12423-cit-0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/shem.2003.50039","article-title":"Quality of life on imatinib","volume":"40","author":"Hahn","year":"2003","journal-title":"Seminars in Hematology"},{"key":"10.1111\/ecc.12423-BIB0010|ecc12423-cit-0010","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.2003.12.154","article-title":"Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study","volume":"21","author":"Hahn","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12423-BIB0011|ecc12423-cit-0011","first-page":"3","article-title":"General health questionnaire: a validity and reliability study","volume":"7","author":"Kilic","year":"1996","journal-title":"Turkish Journal of Psychiatry"},{"key":"10.1111\/ecc.12423-BIB0012|ecc12423-cit-0012","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1200\/JCO.2010.33.2742","article-title":"Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology","volume":"28","author":"Kris","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12423-BIB0013|ecc12423-cit-0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1477-7525-8-104","article-title":"Health care providers underestimate symptom intensities of cancer patients: a multicenter European study","volume":"8","author":"Laugsand","year":"2010","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1111\/ecc.12423-BIB0014|ecc12423-cit-0014","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"Marin","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12423-BIB0015|ecc12423-cit-0015","first-page":"289","volume-title":"Psycho-oncology","author":"Noyes","year":"1998"},{"key":"10.1111\/ecc.12423-BIB0016|ecc12423-cit-0016","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00277-008-0445-4","article-title":"EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies: association with anxiety and depression","volume":"87","author":"Pamuk","year":"2008","journal-title":"Annals of Hematology"},{"key":"10.1111\/ecc.12423-BIB0017|ecc12423-cit-0017","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.25648","article-title":"Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: definitions and clinical implications","volume":"117","author":"Pinilla-Ibarz","year":"2011","journal-title":"Cancer"},{"key":"10.1111\/ecc.12423-BIB0018|ecc12423-cit-0018","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1200\/JCO.2002.08.549","article-title":"Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life","volume":"20","author":"Stark","year":"2002","journal-title":"Journal of Clinical Oncology"}],"container-title":["European Journal of Cancer Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fecc.12423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fecc.12423","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ecc.12423\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:09:33Z","timestamp":1671541773000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ecc.12423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ecc.12423","archive":["Portico"],"relation":{},"ISSN":["0961-5423"],"issn-type":[{"value":"0961-5423","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}